NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE188315 Query DataSets for GSE188315
Status Public on Nov 06, 2021
Title Gene expression profiling of TNBC cells engineered to knock-down or overexpress PTX3
Organism Homo sapiens
Experiment type Expression profiling by array
Summary The pattern recognition receptor long pentraxin-3 (PTX3) plays conflicting roles in cancer by acting as an oncosuppressor or as a pro-tumor mediator depending on tumor context. Triple negative breast cancer (TNBC) represents the most aggressive histotype of breast cancer, characterized by the lack of efficacious therapeutic targets/approaches and poor prognosis. In this study, in silico data and experimental evidences indicate that PTX3 is produced by tumor parenchyma in TNBC and that its expression levels correlate with tumor stage. On this basis, the impact of PTX3 silencing or its overexpression on the tumorigenic potential of TNBC cell lines was analyzed. Gene expression and in vitro results demonstrate that high levels of PTX3 expression confer a high aggressive/proliferative phenotype, fosters stem-like features, and rewires the energy metabolism in TNBC cells. This results in a more tumorigenic potential in vivo when TNBC cells are grafted in immune-compromised and syngeneic animals. Mechanistically, our data reveal a strong positive correlation between PTX3 expression and the antitumor activity of Toll-like receptor 4 (TLR4) inhibition in TBNC, demonstrating for the first time that PTX3-driven TNBC aggressiveness is due to PTX3-mediated activation of TLR4 signaling. Altogether, these data shed light on the role of tumor-produced PTX3 in TNBC and uncover the importance of the PTX3/TLR4 pathway for therapeutic and prognostic exploitation in TNBC.
 
Overall design MDA-MB 231 cells were infected with lentiviral vector containing short-hairpin RNA (shRNA) targeting human PTX3 (TRCN0000436981) (MDA-MB 231 shPTX3) or a non-targeting/control sequence (SHC002V, Merck) (MDA-MB 231 shNT); MDA-MB 468 cells were infected with a pLentiPGK-Puro (Addgene Plasmid #19070) lentiviral vector harbouring (MDA-MB 468 PTX3) or not (MDA-MB 468 mock) the full length human PTX3 cDNA (GenBank accession n° X63613)
 
Contributor(s) Giacomini A, Ronca R
Citation(s) 37749607
Submission date Nov 05, 2021
Last update date Oct 03, 2023
Contact name Roberto Ronca
E-mail(s) roberto.ronca@unibs.it
Organization name University of brescia
Street address viale Europa 11
City Brescia
ZIP/Postal code 25123
Country Italy
 
Platforms (1)
GPL17692 [HuGene-2_1-st] Affymetrix Human Gene 2.1 ST Array [transcript (gene) version]
Samples (12)
GSM5677654 MDA-MB 231 shNT rep1
GSM5677655 MDA-MB 231 shNT rep2
GSM5677656 MDA-MB 231 shNT rep3
Relations
BioProject PRJNA778246

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE188315_RAW.tar 56.6 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap